SCHEMBL17833685

SCHEMBL17833685

O=C(O)CCCCCCc1cc(Cc2ccccc2)cs1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 11/20 0.80
RXFP1 Q9HBX9 2/20 0.57
MAPT P10636 1/20 0.57
HDAC3 O15379 1/20 0.47
MAPK1 P28482 1/20 0.47
ADRA1A P35348 1/20 0.47
HDAC4 P56524 1/20 0.47
SLC6A3 Q01959 1/20 0.47
HDAC1 Q13547 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HDAC9 Q9UKV0 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47
DAO P14920 1/20 0.46
TBXAS1 P24557 5/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14195281 0.89 LTB4R (0.64) LTB4RRXFP1MAPTHDAC1HDAC2
SCHEMBL17833684 0.89 LTB4R (0.89) LTB4RRXFP1MAPTHDAC3MAPK1
SCHEMBL10759925 0.83 LTB4R (0.56) LTB4RRXFP1MAPTHDAC3MAPK1
SCHEMBL10678850 0.80 LTB4R (0.52) LTB4RHDAC1HDAC6DAOALDH1A1
SCHEMBL10717559 0.79 LTB4R (0.56) LTB4RMAPTDAOLMNA
SCHEMBL7045419 0.78 MAPT (0.85) LTB4RRXFP1MAPTHDAC3MAPK1
SCHEMBL13696741 0.78 LTB4R (0.71) LTB4RRXFP1MAPTHDAC1HDAC2
SCHEMBL10795846 0.78 LTB4R (0.63) LTB4RRXFP1MAPTHDAC3MAPK1
Diphenylmethane SCHEMBL10702233 0.78 MAPT (0.69) LTB4RRXFP1MAPTHDAC3MAPK1
SCHEMBL8987510 0.77 MAPT (0.71) LTB4RRXFP1MAPTHDAC3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160166508-A1 Method and Composition for Treating Inflammatory Disorders MEDA AB (SE) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160166508-A1 Method and Composition for Treating Inflammatory Disorders LIPA, HRH2, HRH1 LTB4R 8/4885RXFP1 2472/4885MAPT 2546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.